Endometrial Cancer
Showing NaN - NaN of 61
Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)
Recruiting
- Triple Negative Breast Cancer
- +2 more
-
Oklahoma City, Oklahoma
- +1 more
Nov 13, 2023
Endometrial Cancer Trial in Houston (Paclitaxel, Carboplatin, Dostarlimab)
Not yet recruiting
- Endometrial Cancer
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Apr 6, 2023
Endometrial Cancer Trial in Houston (DKN-01, Pembrolizumab)
Not yet recruiting
- Endometrial Cancer
-
Houston, TexasM D Anderson Cancer Center
Feb 27, 2023
Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified
Recruiting
- Endometrial Cancer
- +8 more
- Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
-
Orlando, Florida
- +21 more
Feb 2, 2023
Endometrial Cancer Who Receive Standard Treatment for Their
Recruiting
- Endometrial Cancer
- +2 more
- Physical exam
-
Hartford, Connecticut
- +19 more
Jan 19, 2023
Gynecologic Cancer, Ovary Cancer, Pancreatic Cancer Trial in Houston (Free genetic testing and counseling group, IGNITE-TX
Not yet recruiting
- Gynecologic Cancer
- +8 more
- Free genetic testing and counseling group
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Jan 11, 2023
Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))
Completed
- Ovarian Cancer
- +7 more
- Enapotamab vedotin (HuMax-AXL-ADC)
-
Phoenix, Arizona
- +40 more
Dec 12, 2022
Biliary Tract Cancer (BTC), Colorectal Cancer (CRC), Endometrial Cancer Trial in Belgium, United Kingdom, United States
Completed
- Biliary Tract Cancer (BTC)
- +5 more
- INCB001158
- +6 more
-
Birmingham, Alabama
- +9 more
Dec 22, 2022
Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)
Active, not recruiting
- Advanced Solid Malignancy
- +13 more
-
Los Angeles, California
- +33 more
Dec 22, 2022
Endometrial Cancer Trial in Morristown, Houston (Letrozole, RAD001 (Everolimus))
Active, not recruiting
- Endometrial Cancer
- Letrozole
- RAD001 (Everolimus)
-
Morristown, New Jersey
- +1 more
Nov 16, 2022
Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States
Recruiting
- Advanced or Metastatic Solid Tumors
- +11 more
-
Tucson, Arizona
- +11 more
Dec 2, 2022
Endometrial Cancer, Ovarian Cancer Trial in Houston (Copanlisib, fulvestrant)
Recruiting
- Endometrial Cancer
- Ovarian Cancer
-
Houston, TexasM D Anderson Cancer Center
Sep 27, 2022
Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)
Recruiting
- Advanced Cancer
- +7 more
-
Scottsdale, Arizona
- +14 more
Sep 15, 2022
ENDOMETRIAL CANCER Trial in Cleveland, Houston (Surgery with UM, Surgery without UM)
Recruiting
- ENDOMETRIAL CANCER
- Surgery with UM
- Surgery without UM
-
Cleveland, Ohio
- +4 more
Sep 6, 2022
Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan
Not yet recruiting
- Endometrial Cancer
- +4 more
- Datopotamab deruxtecan (Dato-DXd)
- +8 more
-
Los Angeles, California
- +52 more
Aug 3, 2022
Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,
Recruiting
- Gynecologic Cancer
- +11 more
- Neoantigen specific TCR-T cell drug product
- Aldesleukin (IL-2)
-
Houston, TexasMD Anderson Cancer Center
Jul 27, 2022
HLA Typing and Tumor Neoantigen Identification forPhase I/II
Recruiting
- Ovarian Cancer
- +5 more
-
Houston, TexasMD Anderson Cancer Center
Jul 27, 2022